Apyx Medical Corporation (FRA:BOV)

Market Cap	132.16M +265.3%
Revenue (ttm)	45.01M +9.9%
Net Income	-9.55M
EPS	-0.23
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	3.260
Previous Close	3.280
Day's Range	3.260 - 3.260
52-Week Range	0.715 - 3.680
Beta	n/a
RSI	54.96
Earnings Date	Mar 10, 2026

About Apyx Medical

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparo...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1982
• Employees: 205
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BOV

Financial Performance

In 2025, Apyx Medical's revenue was $52.84 million, an increase of 9.86% compared to the previous year's $48.10 million. Losses were -$11.21 million, -52.22% less than in 2024.

Financial numbers in USD